Indaptus Therapeutics, Inc. rose 13.3% on Monday, November 2, 2026, on 226,200 shares. No headline about INDP came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
Indaptus Therapeutics, Inc. (INDP:NASDAQ) closed at $3.32 on November 6, 2026, up 5.06% on the day. The stock trades 44.3% below its 52-week high of $5.96 and 260.9% above its 52-week low of $0.920. Over the past year, it gained 32.3%. Indaptus Therapeutics, Inc. is part of the Health Care sector.
In 252 trading sessions since November 6, 2025, INDP closed higher on 114 days (45%). Its best day was June 4, 2026 (+114.93%) and its worst was June 8, 2026 (-42.62%). The stock moved 10% or more in a single session 61 times. It opened at least 5% above the previous day's high 5 times.
Indaptus Therapeutics Inc is positioned to revolutionize the treatment of cancer and certain infectious diseases. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. Its pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma in standard pre-clinical models.
Find more stocks like INDP with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.